Your tailored API risk assessment

The SmartPath forward

De-risking your pharmaceutical pipeline is our mission

Our Director of Material Sciences, Dr Robert Dennehy will work with you to identify and mitigate the risks in your API process. Together, you and Robert will devise a perfect-for-purpose process development roadmap, allowing you to rapidly take the right steps to accomplish your project objectives. First Time, Every Time.

Why Take The SmartPath?

Expert one-to-one consultancy

De-risk your pharmaceutical pipeline by working alongside our Director of Material Sciences, Dr Robert Dennehy. Dr Dennehy will leverage your already available API, project and formulation data sets to assess the risks of your API process and offer smart mitigation strategies.

Faster and smarter decisions

Better understand your project risks and set the right priorities based on your portfolio needs. Rapidly reach the best decision for your process – First Time, Every Time.

Perfect-for-purpose Process Development Roadmap

Advance your asset to the next step, without surprises or delays. Receive a tailored life-cycle plan of your API to meet your budget, timelines and study needs.

What’s Included:

  • Comprehensive assessment of API, project and formulation data
  • Identification of risks
  • Expert, one-to-one consultancy with our Director of Material Sciences, Dr Robert Dennehy
  • Tailored process development roadmap
  • Knowledge gap identifier

Meet Robert